Aluminium as a risk factor in Alzheimer's disease, with emphasis on drinking water.

By T. Flaten. Brain Research Bulletin, 2001

892 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Removal of natural organic matter in drinking water treatment by coagulation: A comprehensive review. (2018, background): “Lately, the application of ferric coagulants is gaining ground over the aluminum counter parts mainly due to the suspected health risks associated with residual aluminum (Flaten, 2001) and the better NOM removal capacities of ferric coagulants.”
Removal of antibiotic resistance genes (ARGs) in various wastewater treatment processes: An overview (2020, background): “Aluminum-based coagulants, such as Al2[SO4]3, polyaluminium chloride (PAC) and alum, are generally considered to be a potential risk factor for public health, such as Alzheimer’s disease or other diseases related to residual aluminum, despite its low price and simple use (Flaten, 2001).”
Human Health Risk Assessment for Aluminium, Aluminium Oxide, and Aluminium Hydroxide (2007, background): “However, operational filtering processes in treatment plants using aluminium coagulation can remove or add to the residual dissolved forms in drinking water ( Berube, 2004 ; Cech & Montera, 2000 ; Flaten, 2001 ).”
A new look at biomedical Ti-based shape memory alloys. (2012, background): “Al is already utilized in an existing biomedical alloy, Ti–6Al–4V, but links to neurodegenerative disease, genotoxicity and possible necrosis have been reported in the literature [19,30,47].”